CTI BIOPHARMA CORP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 851-875 of 1,000 matching filings.

Per page
25
Current page
35
DEF 14A File 001-12465

DEF 14A

Filing date
28 Mar 2014
Reporting date
22 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

8-K

Filing date
27 Mar 2014
Reporting date
27 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Mar 2014
Reporting date
25 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Mar 2014
Reporting date
24 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Mar 2014
Reporting date
21 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Mar 2014
Reporting date
20 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Mar 2014
Reporting date
21 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-12465

PRELIMINARY PROXY STATEMENT

Filing date
11 Mar 2014
Reporting date
18 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2014
Reporting date
07 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2014
Reporting date
07 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
04 Mar 2014
Reporting date
04 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
04 Mar 2014
Reporting date
04 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
03 Mar 2014
Reporting date
03 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
28 Feb 2014
Reporting date
28 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
27 Feb 2014
Reporting date
27 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48459

SC 13G/A filing

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12465

FORM 8-K

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
14 Feb 2014
Reporting date
14 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12465

SOLICITING MATERIALS

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2014
Reporting date
31 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2014
Reporting date
31 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12465

FORM 8-K

Filing date
03 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12465

FORM 8-K

Filing date
03 Feb 2014
Reporting date
31 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .